Call Options

2 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2020

Nov 16, 2020

SELL
$53.07 - $61.1 $3.71 Million - $4.28 Million
-70,000 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$43.1 - $55.31 $3.02 Million - $3.87 Million
70,000 New
70,000 $3.7 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $208B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Baymount Management LP Portfolio

Follow Baymount Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baymount Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Baymount Management LP with notifications on news.